Arena Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (53)

Latest Posts

About This Stock More About This Stock
Biotech Investing Guide: 3 Stocks To Buy And 3 To Avoid
Article By: Arpita Dutt
Friday, March 11, 2016 2:10 PM EDT
Anyone interested in biotech stocks will know that it could be challenging to pick winners in this industry which is constantly growing and changing. We have zeroed in on 3 biotech stocks to buy and 3 to avoid.
In this article: ARNA, MNTA, REGN, AMGN, CELG, GILD Also: ABBV
Read
E Arena Pharmaceuticals Announces Collaboration With Privately Held Boehringer Ingelheim
Article By: Terry Chrisomalis
Tuesday, January 12, 2016 6:37 PM EDT
Arena stands to make more than $250 million in milestone payments.
In this article: ARNA
Read
Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected
Article By: Zacks Investment Research
Tuesday, May 12, 2015 6:27 AM EDT
Arena Pharmaceuticals, Inc. (ARNA) reported a first-quarter 2015 loss of 10 cents per share, narrower than the Zacks Consensus Estimate of a loss of 14 cents and the year-ago loss of 12 cents.
In this article: ARNA, ESALY Also: GILD, ALIOF
Read
Strongest Stocks On StockTwits Last Week
Article By: Blair Jensen
Thursday, March 19, 2015 1:42 PM EDT
Over the past week here are the stocks with the most bullish messages from the StockTwits community.
In this article: AMRN, TWTR, DIS, REGN, V, ORCL, ARNA, SBUX, FDX, MS, WFC, GM
Read
Shares Of Orexigen Soar After It Announces Improved Safety Results For Weight-Loss Drug
Article By: Terry Chrisomalis
Tuesday, March 3, 2015 2:37 PM EDT
Orexigen's drug Contrave shows not only shows great safety but also shows the ability to reduce heart-related problems as compared to placebo.
In this article: OREX, ARNA, VVUS
Read

PARTNER HEADLINES

Latest Tweets for $ARNA

No tweets yet!